ABBV

AbbVie, Inc. · VIE:ABBV

257.50 EUR−0.1000 −0.04%

AbbVie, Inc. (VIE:ABBV) last traded at 257.50 EUR, down 0.04% on the day. Over the past year the stock is up 35.81%. Its 52-week range is 164.30 to 265.70. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open257.20

Day range257.20 – 257.50

52-week range164.30 – 265.70

Volume0

Average volume (10 days)0

Market cap (USD)510.41 B

P/E50.14

EPS (TTM) (USD)5.82

Dividend yield2.40%

Beta (1 year)−0.4295

Revenue (TTM) (USD)66.01 B

Employees57.00 K

Performance

−1.42%1 week

+11.38%1 month

+21.12%3 months

+47.06%6 months

+32.32%Year to date

+35.81%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

AbbVie Is Maintained at Neutral by UBSDow Jones Newswires · 02 Nov 2026
AbbVie Is Maintained at Outperform by Leerink PartnersDow Jones Newswires · 02 Nov 2026
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestMarketBeat · 02 Nov 2026
AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology TransitionGuruFocus · 02 Nov 2026
AbbVie Price Target Raised to $346.00/Share From $310.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks · 02 Nov 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.